Live
Fed signals a patient path on rate cutsData-center power crunch reshapes site selectionMultifamily supply wave peaks in Sun BeltIndustrial last-mile assets repriceRecord dry powder waits on the sidelinesFed signals a patient path on rate cutsData-center power crunch reshapes site selectionMultifamily supply wave peaks in Sun BeltIndustrial last-mile assets repriceRecord dry powder waits on the sidelines

Lab Demand Is Up 44% and Landlords Are Losing Anyway

Vacancy near 32% has cut lease terms by 30% — the recovery is arriving on tenants' paper.

C3S

CRE 360 Signal

Jul 20, 2026 1 min Share
Lab Demand Is Up 44% and Landlords Are Losing Anyway

The Signal:

  • Demand recovery and landlord recovery are not the same event.
  • Vacancy this deep converts rising demand into shorter, cheaper leases.
  • Duration, not occupancy, is where lab value is being destroyed.

Lab leasing demand across Boston, the Bay Area, San Diego, and Raleigh-Durham surged 44% year over year to nearly 8 million square feet in Q1. On most tapes that is a recovery headline. Here it is not, because vacancy across Boston, San Diego, and the Bay Area sits near 32% — Boston alone around 33%.

When one in three feet is empty, incremental demand does not set price. It sets terms. Average lease terms for direct relocations have compressed to 62 months, roughly 30% shorter than at the market peak, alongside record free rent and pre-built space.

That is the number that matters for value. A 62-month weighted average lease term is a fundamentally different asset than the ten-year credit lease lab was underwritten as. Shorter duration means more frequent rollover, more recurring TI and leasing costs, and a higher cap rate on identical NOI.

San Diego shows where this lands: a sub-10% core against a sharply weaker outer ring. The recovery is real and it is narrow.

Implications: Owners should underwrite lab as a shorter-duration, higher-capex asset class and stop modeling peak-vintage lease terms. Tenants hold genuine leverage and should be trading term for concessions now. For lenders, the risk has moved from lease-up to re-lease frequency — the diligence question is what the rollover schedule and TI reserve look like in year five, not whether the building fills.

Key Takeaways

  • Lab demand is recovering and lab value is not — at 32% vacancy, rising demand buys tenants shorter terms, and duration is where the loss shows up.
  • Demand recovery and landlord recovery are not the same event
  • Vacancy this deep converts rising demand into shorter, cheaper leases
  • Duration, not occupancy, is where lab value is being destroyed

JLL — U.S. Life Sciences Real Estate Has Reached Its Turning Point, June 2026 · Bisnow — Vacancy Has Peaked For Life Sciences, 2026 · Bisnow — Lab Rents Down 20% In Boston, But A Deeper Reset May Be Needed, 2026

Never miss a Signal

Get the daily brief that busy CRE professionals rely on.

Trusted Daily

40,000+

Daily Subscribers

Brokers, investors, developers, and lenders open CRE 360 Signal every morning for the market intelligence that moves their decisions.

Free. Independent. Editorially rigorous.

Follow the Signal

Add your profile URLs from the Editorial Desk → Social links.